Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm Provides Phase 3 Clinical Trial Update

Dec 14, 2020 at 2:44 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment